Article
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease
1 Jan 2011
Abstract excerpt
Natural and synthetic glucocorticoids (GCs) are widely employed in a number of inflammatory, autoimmune and neoplastic diseases, and, despite the introduction of novel therapies, remain the first-line treatment for inducing remission in moderate to severe active Crohn's disease and ulcerative colitis. Despite their extensive therapeutic use and the proven effectiveness, considerable clinical evidence of wide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.